Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > AL Providers > Neurologists

Dr. Christopher Cole Laganke, MD

(Dr. Christopher C. Laganke, MD)

(15 Ratings)

Specializes in: Neurology (Brain & Spinal Cord Disease)

Meharry Medical College (1990)

1809 Kress Street
Cullman, AL 35058

(256) 739-1210

Dr. Christopher Cole Laganke, MD is a neurologist in Cullman, AL specializing in neurology (brain & spinal cord disease). He graduated from Meharry Medical College in 1990 and has 36 years of experience. Dr. Christopher Cole Laganke, MD is affiliated with NORTH CENTRAL NEUROLOGY ASSOCIATES, PC.

Office Locations

1809 Kress Street
Cullman, AL 35058

open_in_new

1809 Kress Street
Ne Cullman, AL 35058

open_in_new

Noteworthy Medicare Patient Procedures Performed by Dr. Christopher Cole Laganke, MD in 2024

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

minimally invasive procedures

By Affordability:

biological response modifier therapy

chemotherapy

intravenous infusion therapy

intravenous chemotherapy

lab tests

urinalysis

urine tests

In 2024, among providers in related specialties within Alabama, Dr. Christopher Cole Laganke, MD performed more minimally invasive procedures procedures for Medicare patients than 95% of them and he also had a list price for biological response modifier (BRM) therapy, chemotherapy, intravenous infusion therapy, intravenous (IV) chemotherapy, lab tests, urinalysis, and urine tests that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

botulinum toxin injection for migraine

By Affordability:

diagnostic procedures

electrodiagnostic testing

electrophysiological study

intravenous infusion

nerve conduction studies

In 2012, among providers in related specialties within Alabama, Dr. Christopher Cole Laganke, MD performed more botulinum toxin injection for migraine procedures for Medicare patients than 75% of them and he also had a list price for diagnostic procedures, electrodiagnostic testing, electrophysiological (EP) study, intravenous (IV) infusion, and nerve conduction studies (NCS) that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2012 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and blood draw.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1504
blood draw	504
chemotherapy	1504
diagnostic procedures	250
doctor visit	1538
electroencephalography (EEG)	53
injections	84
lab tests	398
minimally invasive procedures	1810

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2013 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and blood draw.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1627
blood draw	558
chemotherapy	1627
diagnostic procedures	11
doctor visit	1559
electroencephalography (EEG)	39
injections	118
lab tests	261
minimally invasive procedures	1977

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	253
Female	577

**Ethnicity**
Non-Hispanic White	779
Black	41
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	223
From 75 to 84	108
85 and over	30
Less than 65	469

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2013

Hypertension	52
High Cholesterol	41
Stroke	12
Ischemic Heart Disease	20
Depression	35
Chronic Kidney Disease	11
Asthma	7
Osteoperosis	5
Atrial Fibrilation	5
Heart Failure	15
Chronic Obstructive Pulmonary Disease	13
Diabetes	24
Dementia	12
Cancer	5

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2014 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and blood draw.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1744
blood draw	698
chemotherapy	1744
doctor visit	1539
electroencephalography (EEG)	72
injections	211
lab tests	205
minimally invasive procedures	2292

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	263
Female	642

**Ethnicity**
Non-Hispanic White	848
Black	40
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	237
From 75 to 84	107
85 and over	31
Less than 65	530

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2014

Hypertension	52
High Cholesterol	41
Stroke	14
Ischemic Heart Disease	20
Depression	41
Chronic Kidney Disease	11
Asthma	6
Osteoperosis	6
Atrial Fibrilation	5
Heart Failure	13
Chronic Obstructive Pulmonary Disease	10
Diabetes	23
Dementia	12
Cancer	5

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2015 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and blood draw.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1845
blood draw	908
chemotherapy	1845
diagnostic procedures	16
doctor visit	1730
electroencephalography (EEG)	92
evoked potential test	11
injections	301
lab tests	348
minimally invasive procedures	2581

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	582
Female	1486

**Ethnicity**
Non-Hispanic White	1934
Black	88
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	540
From 75 to 84	184
85 and over	62
Less than 65	1282

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2015

Hypertension	52
High Cholesterol	38
Stroke	11
Ischemic Heart Disease	20
Depression	41
Chronic Kidney Disease	15
Asthma	11
Osteoperosis	5
Atrial Fibrilation	4
Heart Failure	13
Chronic Obstructive Pulmonary Disease	12
Diabetes	23
Dementia	12
Cancer	5

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2016 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and blood draw.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1571
blood draw	539
chemotherapy	1571
diagnostic procedures	11
doctor visit	1469
electroencephalography (EEG)	50
injections	349
lab tests	338
minimally invasive procedures	2397

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	270
Female	687

**Ethnicity**
Non-Hispanic White	887
Black	46
Hispanic	0
Asian	0
Other	12
Native American	0

**Age**
From 65 to 74	227
From 75 to 84	91
85 and over	21
Less than 65	618

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2016

Hypertension	56
High Cholesterol	37
Stroke	6
Ischemic Heart Disease	20
Depression	38
Chronic Kidney Disease	19
Asthma	14
Osteoperosis	6
Atrial Fibrilation	3
Heart Failure	14
Chronic Obstructive Pulmonary Disease	10
Diabetes	22
Dementia	10
Cancer	3

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2017 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and injections.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1309
chemotherapy	1309
doctor visit	1196
electroencephalography (EEG)	18
injections	275
lab tests	156
minimally invasive procedures	2011

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	208
Female	616

**Ethnicity**
Non-Hispanic White	749
Black	53
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	198
From 75 to 84	70
85 and over	11
Less than 65	545

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2017

Hypertension	50
High Cholesterol	30
Stroke	4
Ischemic Heart Disease	16
Depression	39
Chronic Kidney Disease	17
Asthma	7
Osteoperosis	5
Atrial Fibrilation	3
Heart Failure	11
Chronic Obstructive Pulmonary Disease	10
Diabetes	20
Dementia	8
Cancer	4

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2018 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and injections.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1139
chemotherapy	1139
doctor visit	1114
electroencephalography (EEG)	15
injections	269
lab tests	54
minimally invasive procedures	1921

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	187
Female	588

**Ethnicity**
Non-Hispanic White	704
Black	47
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	202
From 75 to 84	58
85 and over	15
Less than 65	500

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2018

Hypertension	54
High Cholesterol	38
Stroke	4
Ischemic Heart Disease	17
Depression	44
Chronic Kidney Disease	18
Asthma	6
Osteoperosis	7
Atrial Fibrilation	3
Heart Failure	11
Chronic Obstructive Pulmonary Disease	11
Diabetes	22
Dementia	8
Cancer	5

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2019 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and injections.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	1057
chemotherapy	1057
doctor visit	1014
electroencephalography (EEG)	13
injections	230
lab tests	57
minimally invasive procedures	1727

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	169
Female	549

**Ethnicity**
Non-Hispanic White	658
Black	36
Hispanic	0
Asian	0
Other	12
Native American	0

**Age**
From 65 to 74	204
From 75 to 84	59
85 and over	16
Less than 65	439

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2019

Hypertension	55
High Cholesterol	41
Stroke	5
Ischemic Heart Disease	18
Depression	45
Chronic Kidney Disease	19
Asthma	6
Osteoperosis	7
Atrial Fibrilation	4
Heart Failure	11
Chronic Obstructive Pulmonary Disease	12
Diabetes	21
Dementia	8
Cancer	5

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2020 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and injections.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	891
chemotherapy	891
diagnostic procedures	11
doctor visit	936
injections	234
lab tests	43
minimally invasive procedures	1614

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	158
Female	509

**Ethnicity**
Non-Hispanic White	615
Black	30
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	210
From 75 to 84	0
85 and over	0
Less than 65	391

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2020

Hypertension	55
High Cholesterol	39
Stroke	3
Ischemic Heart Disease	19
Depression	43
Chronic Kidney Disease	21
Asthma	8
Osteoperosis	6
Atrial Fibrilation	3
Heart Failure	11
Chronic Obstructive Pulmonary Disease	11
Diabetes	22
Dementia	7
Cancer	6

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2021 were minimally invasive procedures, injections, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	147
chemotherapy	147
doctor visit	882
injections	231
lab tests	30
minimally invasive procedures	1459

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	142
Female	462

**Ethnicity**
Non-Hispanic White	557
Black	24
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	207
From 75 to 84	50
85 and over	15
Less than 65	332

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2021

Hypertension	59
High Cholesterol	43
Stroke	5
Ischemic Heart Disease	22
Depression	42
Chronic Kidney Disease	22
Asthma	6
Osteoperosis	7
Atrial Fibrilation	3
Heart Failure	10
Chronic Obstructive Pulmonary Disease	10
Diabetes	23
Dementia	8
Cancer	5

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2022 were minimally invasive procedures, injections, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	159
chemotherapy	159
diagnostic procedures	13
doctor visit	847
injections	174
lab tests	28
minimally invasive procedures	1286

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	145
Female	452

**Ethnicity**
Non-Hispanic White	547
Black	30
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	209
From 75 to 84	0
85 and over	0
Less than 65	314

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2022

Hypertension	63
High Cholesterol	54
Stroke	9
Ischemic Heart Disease	15
Depression	32
Chronic Kidney Disease	12
Asthma	9
Osteoperosis	11
Atrial Fibrilation	7
Heart Failure	9
Chronic Obstructive Pulmonary Disease	13
Diabetes	24
Dementia	5
Cancer	8

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2023 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and injections.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	171
chemotherapy	171
doctor visit	762
injections	168
lab tests	21
minimally invasive procedures	1164

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	118
Female	425

**Ethnicity**
Non-Hispanic White	500
Black	22
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	189
From 75 to 84	0
85 and over	0
Less than 65	283

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2023

Hypertension	66
High Cholesterol	57
Stroke	8
Ischemic Heart Disease	15
Depression	34
Chronic Kidney Disease	14
Asthma	9
Osteoperosis	15
Atrial Fibrilation	7
Heart Failure	10
Chronic Obstructive Pulmonary Disease	12
Diabetes	25
Dementia	4
Cancer	8

Medicare Procedure and Patient Information

2024 Medicare Procedure Volume

The top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL during 2024 were minimally invasive procedures, injections, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

biological response modifier (BRM) therapy	148
chemotherapy	148
diagnostic procedures	13
doctor visit	700
injections	183
lab tests	14
minimally invasive procedures	1075

2024 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Male	114
Female	440

**Ethnicity**
Non-Hispanic White	510
Black	26
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	212
From 75 to 84	0
85 and over	0
Less than 65	260

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2024

Hypertension	67
High Cholesterol	62
Stroke	7
Ischemic Heart Disease	16
Depression	40
Chronic Kidney Disease	15
Asthma	9
Osteoperosis	15
Atrial Fibrilation	8
Heart Failure	10
Chronic Obstructive Pulmonary Disease	12
Diabetes	25
Dementia	5
Cancer	9

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2024

Volume of procedures performed by Dr. Christopher Cole Laganke, MD for Medicare patients.

The highest averages for the top procedures that Dr. Christopher Cole Laganke, MD treated as a neurologist in Cullman, AL were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and blood draw.

biological response modifier (BRM) therapy	1024
blood draw	641
chemotherapy	1024
diagnostic procedures	46
doctor visit	1175
electroencephalography (EEG)	44
evoked potential test	11
injections	217
lab tests	150
minimally invasive procedures	1793

Average Medicare Patient Data From 2012 - 2024

Information about Medicare patients treated by Dr. Christopher Cole Laganke, MD.

**Gender**
Female	571
Male	200

**Ethnicity**
Black / African American	37
Asian / Pacific Islander	0
Non-Hispanic White	714
Hispanic	0
Native American / Alaskan Native	0
Other	1

**Age**
85 and over	15
75 to 84	55
Less than 65	458
65 to 74	219

Average of Total of Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD From 2012 - 2024

The highest averages of the most common conditions of Medicare patients that Dr. Christopher Cole Laganke, MD treated were hypertension, high cholesterol, depression and diabetes.

Hypertension	52
High Cholesterol	40
Stroke	6
Ischemic Heart Disease	16
Depression	36
Chronic Kidney Disease	14
Asthma	7
Osteoporosis	7
Heart Failure	10
Chronic Obstructive Pulmonary Disease	10
Diabetes	21
Atrial Fibrillation	4
Dementia	7
Cancer	5

Education & Training

Dr. Christopher Cole Laganke, MD graduated from Meharry Medical College in 1990. He has a state license in Alabama.

Medical School: Meharry Medical College (1990)

Licensed In: Alabama

Ratings & Reviews

Dr. Christopher Cole Laganke, MD has an exceptional overall rating with an average of 4.5 out of 5 stars based on 15 ratings. We collect ratings and reviews of Dr. Christopher Cole Laganke, MD from all over the web to help you find the right in Cullman, AL.

4.5

Overall Rating

(15 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Christopher Cole Laganke, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
GENZYME CORPORATION	$550,257 LEMTRADA $217,044	AUBAGIO $200,613	ALEMTUZUMAB $69,265	DISEASE STATE $16,704	MS DISEASE STATE $117	Other $46,515
Biogen, Inc.	$244,435 TYSABRI $80,691	Vumerity $67,728	TECFIDERA $21,641	PLEGRIDY $14,480	ZINBRYTA $210	Other $59,685
EMD Serono, Inc.	$224,955 Mavenclad $152,414	Rebif $29,486	Evobrutinib $10,425	$32,629
Novartis Pharmaceuticals Corporation	$167,175 Gilenya $128,499	NON BRAND $20,881	MAYZENT $14,054	KESIMPTA $2,595	Aimovig $328	Other $817
Questcor Pharmaceuticals	$89,211 ACTHAR $89,211
Other	$613,461 Betaseron $68,938	ACTHAR $52,643	OCREVUS $50,095	TYSABRI $47,954	COPAXONE $46,445	Other $347,386

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$1,050,688
Consulting Fee	$401,043
Travel and Lodging	$204,092
Honoraria	$97,897
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$69,350
Other	$66,424

Research Payments

Dr. Christopher Cole Laganke, MD has received 1084 research payments totaling $13,306,547.

Biography

Dr. Christopher Laganke practices neurology (brain & spinal cord disease) in Cullman, AL and Ne Cullman, AL. Dr. Laganke has a 4.5 out of 5 star average patient rating.

Select Year:

Dr. Christopher Cole Laganke, MD

Office Locations

Noteworthy Medicare Patient Procedures Performed by Dr. Christopher Cole Laganke, MD in 2024

By Volume:

By Affordability:

By Volume:

By Affordability:

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

2021 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2021

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

2022 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2022

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

2023 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2023

Medicare Procedure and Patient Information

2024 Medicare Procedure Volume

2024 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD in 2024

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2024

Average Medicare Patient Data From 2012 - 2024

Average of Total of Conditions of Medicare patients treated by Dr. Christopher Cole Laganke, MD From 2012 - 2024

Education & Training

Ratings & Reviews

General Payments

Research Payments

Biography

Neurologists in Nearby Locations

Other Providers in Cullman, AL